3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer - Wikidata - awgldk - TriplyDB

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

http://www.wikidata.org/entity/Q36028261

about

Medical management of hypercalcaemia.Pamidronate.Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.Metabolic effects of pamidronate in patients with metastatic bone disease.Current management strategies for hypercalcemia.Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.TGF-beta and BMP7 interactions in tumour progression and bone metastasis.Bone targeted treatments in cancer - The story so far Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature.Treatment of hypercalcaemia of malignancy.Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study.

P2860

Q34403106-2ACF8B67-6C03-4841-9E7B-B70C82677D96 Q35466455-B29EE81D-014E-4596-BC56-65CF49C6F055 Q35976111-2CFA92E8-9DAA-424A-A986-A8FAAB710D47 Q36134905-DE3CC8C5-28CE-4ADB-A312-D3C956615DB3 Q36168196-D30006AB-F5F2-46EF-80CB-EFB85E4948EF Q36466740-4F4405FA-1DF9-49F9-96B5-B90F510F64D4 Q36544980-DE80450C-E1F3-4F94-8415-99D33B44BBE7 Q37002892-7C1B56CD-9785-49C0-83D0-91E0469F1A6E Q37337487-1E1DD1AD-9553-40D8-8BBB-8C41CA4830FC Q37708869-D3A43E72-1523-45CC-9145-65901B2B66F9 Q42739037-714324C5-177E-44D1-9343-5C89D180C572 Q46191356-C5D72DF2-EA60-44FE-8B88-81F77401EFB7

P2860

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

http://www.wikidata.org/entity/Q36028261

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

1987年论文

@zh

1987年论文

@zh-cn

name

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

@ast

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

@en

type

label

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

@ast

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

@en

prefLabel

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

@ast

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

@en

P1433

Q36028261-314C5D63-8729-4EF2-830A-6A4DA83706B7

P1476

Q36028261-40898DE2-148B-4D26-B965-B246AD3CD4D9

P2093

Q36028261-430FF5A2-EBD8-48FA-BB74-D981A0C15D3E

Q36028261-44600DD7-6EEE-464B-AA9B-95EB58CC6DFF

P2860

Q36028261-0C1258E1-F19F-4DFB-A27E-F95DA14FFF78

Q36028261-0C9295F9-4809-405C-9F9F-FCFC2BCB27BD

Q36028261-1DF55EC8-8396-4310-9287-88116DF9566C

Q36028261-25DD8662-B6BA-4B00-946B-E2EE4072EA7A

Q36028261-517AA980-A1F6-4D58-8D95-A333880A7D92

Q36028261-53BB34ED-1504-427C-91C4-D06AAA5DC380

Q36028261-573246D3-F8A3-4183-8F0A-BF03DA237B88

Q36028261-5B642CEF-45BC-4737-98DB-BEF5A938554A

Q36028261-836BB742-4E38-4F3D-9339-F5A758A88575

Q36028261-9629E0AC-9454-4797-A2A4-C2F81EEA8DFE

P2888

Q36028261-4D5CDAB2-884D-4172-ADF4-4813B19C7B26

P304

Q36028261-57897FC7-1DA6-4BB6-A3AF-E7D74DC88204

P31

Q36028261-CA139FA6-E843-4A3E-ADAD-883F52DDF63B

P356

Q36028261-A65B7FCF-79B3-4884-87C8-AA9FA8CE0C60

P407

Q36028261-978F72DF-9C6F-4698-A4CA-E46951B3334F

P433

Q36028261-68251D44-549F-4768-9A52-90182336DF47

P478

Q36028261-60AEE928-77C3-4EA5-8263-F572023A972F

P577

Q36028261-E03995FA-7F32-48D7-A99A-8EFEB2377198

P5875

Q36028261-54408659-7E3F-4702-8C85-7849826D8F31

P698

Q36028261-F43709CF-8012-492F-8364-24B93E4C2F7C

P932

Q36028261-BD89CD07-4187-4D78-B113-55AB87CDD123

P356

P1433

British Journal of Cancer

P1476

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

@en

P2093

Coleman RE

http://www.w3.org/2001/XMLSchema#string

Rubens RD

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.

Mechanism of malignant hypercalcaemia in carcinoma of the breast

Tumor products and the hypercalcemia of malignancy.

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.

Role of glucocorticoids in management of malignant hypercalcaemia.

Treatment of malignant hypercalcaemia with clodronate.

The clinical course of bone metastases from breast cancer.

Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.

Pathogenesis of hypercalcaemia of malignancy.

Cancer hypercalcemia: recent advances in understanding and treatment.

P2888

P304

465-469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1987.225

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

1987-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19471600

http://www.w3.org/2001/XMLSchema#string

P698

3689664

http://www.w3.org/2001/XMLSchema#string

P932

2001821

http://www.w3.org/2001/XMLSchema#string